The Medicines Company announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 48.001 million compared to USD 52.571 million a year ago. Net loss was USD 60.055 million compared to USD 54.197 million a year ago. Basic loss per share was USD 0.8 compared to USD 0.74 a year ago. For the half year, operating loss was USD 91.994 million compared to USD 116.854 million a year ago. Net loss was USD 119.920 million compared to USD 25.048 million a year ago. Basic loss per share from continuing operations was USD 1.62 compared to USD 1.89 a year ago. Basic loss per share was USD 1.62 compared to USD 0.34 a year ago.